Alcidion's New Contract Improves U.K. Credibility -- Market Talk

Dow Jones

05/26

0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.K., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

May 25, 2026 21:34 ET (01:34 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2638569006"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2638569006\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2638569006?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 09:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638569006","market":"sg","top_or_hot":-1,"title":"Alcidion's New Contract Improves U.K. Credibility -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 25, 2026 21:34 ET (01:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alcidion's New Contract Improves U.K. Credibility -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlcidion's New Contract Improves U.K. Credibility -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-26 09:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 25, 2026 21:34 ET (01:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2638569006","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638569006","pubTimestamp":1779759240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.K., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","ALC.AU":"ALCIDION GROUP LTD"},"translate_title":"Alcidion的新合同提高了英国的可信度——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALC.AU":0.9},"content_text":"0134 GMT - Alcidion's latest contract provides further credibility for future competitive tenders in the U.K., according to the medical-tech provider's bull at Bell Potter. Analyst Thomas Wakim says the A$8.5 million up-front component of Alcidion's deal with UHSussex provides increased confidence that the Australian company will achieve its FY26 Ebitda guidance. Raising his FY26 revenue forecast, Wakim tells clients in a note that he wouldn't be surprised if UHSussex adds additional modules over the coming years. He sees further contract announcements as the most likely stock catalysts over the coming months. Bell Potter keeps a buy rating and A$0.16 target price on the stock, which is up 2.3% at A$0.1125. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 25, 2026 21:34 ET (01:34 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}